EYPT, STLA, ENVX US Stocks Hit 52-Week Lows on Trial Failure, Recall, CEO Exit
EyePoint Inc. (EYPT), Stellantis N.V. (STLA), and Enovix Corp. (ENVX) US stocks fell to 52-week or record lows on Monday. EyePoint dropped nearly 67% after its Phase 3 LUGANO trial for wet age-related macular degeneration failed to meet its primary non-inferiority goal. Stellantis declined 4%
LucasBennett·08-18 03:03


